Roman516
12 minutes ago
NoGro,
"20+ years in biopharma, I have very good understanding of the basics including FDA Guidelines that NWBO violated repeatedly with protocol revisions, endpoint changes at the last minute, adding new trial arm two weeks before the end of the trial, comparator change that was required BE